Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2008
11/18/2008US7452994 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/18/2008CA2340912C Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008135746A2 Natural bioactive compounds
11/13/2008US20080281111 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/13/2008US20080281110 resolving enantiomerically impure citalopram via diastereomeric salt crystallizationcomprises using L-tartaric acid as the resolving agent in the presence of formaldehyde
11/13/2008US20080281095 Asparatyl protease inhibitor
11/13/2008US20080281074 Delivering nucleic acids to cells; complexing nucleic acid with polyampholte; contacting cell; biocompatible in vivo delivery; gene therapy
11/13/2008US20080281073 High-Purity Oxydiphthalic Acid Anhydride and Process for Producing the Same
11/13/2008US20080280977 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/13/2008US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
11/13/2008CA2686383A1 Natural bioactive compounds
11/13/2008CA2685389A1 Tricyclic compounds as matrix metalloproteinase inhibitors
11/12/2008EP1989162A1 Cycloalkylphenyl substituted cyclic ketoenols
11/12/2008EP1727808B1 Biaryl amino acids and their use in dna binding oligomers
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008EP1346988B1 Process for preparing optically active 2,3-dihydro- benzofuran compounds
11/12/2008EP1305284B1 Process and intermediate compounds for the preparation of pyrrolidines
11/12/2008CN101302209A Method for preparing phthalide by benzoic anhydride liquid phase hydrogenation with gold-base catalyst
11/12/2008CN101302208A Compound inhibiting glutathion S-transferase activity, preparation and use thereof
11/12/2008CN101302207A Preparation of 3-o-alkyl-5,6-o-(1-methyl ethylidine)-l-ascorbic acid and preparation of 5,6-o-(1- methyl ethylidine)-l- ascorbic acid
11/12/2008CN101302206A Method for preparing furfural with maize
11/12/2008CN100432076C Camptothecine derivative, preparing method and use
11/12/2008CN100432065C Lactone monomer compound and its application in preparing anticancer medicine
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100431702C Vanadium/phosphorus mixed oxide catalyst precusor, active catalyst for preparing maleic anhydride and method of preparing maleic anhydride
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/06/2008WO2008133441A1 Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
11/06/2008WO2008116663A3 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
11/06/2008US20080275253 Lewis acid catalyzed halogenation of activated carbon atoms
11/06/2008US20080275247 Sulphur-containing metathesis catalysts
11/06/2008US20080275211 in a liquid phase reaction of halogen-substituted ortho-xylene with oxygen and acetic acid, in the presence of oxidation catalysts; chemical intermediates for the synthesis of polyetherimide copolymers
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275016 For drug resistant cancers; antiinflammatory agents;degenerative or vascular diseases; blocking nitrogen oxide so growth of tumors is suppressed
11/06/2008US20080274893 Spirocyclic 3-Phenyl-3substituted-4-Ketolactams and-lactones
11/06/2008US20080274517 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
11/06/2008US20080274058 substrates for amyloidogenic proteins, for example, A beta 1-42, an amyloid protein, brain deposits of which are associated with Alzheimer's disease
11/06/2008DE102007020694A1 Schwefelhaltige Metathesekatalysatoren Sulfur-containing metathesis catalysts
11/05/2008EP1988087A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases
11/05/2008EP1988086A1 Process for resolving citalopram via its (S)-enriched citalopram tartrate compound.
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1987016A1 An improved process for the preparation of escitalopram
11/05/2008EP1987015A2 Benzoyl-substituted alanines
11/05/2008EP1534276B1 Non-nucleoside reverse transcriptase inhibitors
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008CN101300245A Process for producing 6,6-dimethyl-3-oxabicyclo[3.1.0]hexan-2-one
11/05/2008CN101300244A Novel cercosporamide derivative
11/05/2008CN101300243A O-substituted aniline derivative and antioxidant drug
11/05/2008CN101300005A N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/05/2008CN101298446A Industrialized production process of benzoic anhydride
11/05/2008CN101298445A Method for directly preparing vitamin C with sodium gulonate
11/05/2008CN101298444A Method for preparing tetrahydrofuran by dehydration and cyclization of 1,4-butanediol
11/05/2008CN101297828A Uses of Petasites tricholobus franch extract in medicament preparation for preventing and controlling cardiovascular and cerebrovascular diseases
11/05/2008CN100430387C 6,7-dihydroligustilide and alkylidene phthalide synthesis method
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446219 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/04/2008US7446214 Solution containing a dianhydride compound, a solvent, and a phase transfer catalyst is contacted with a solid inorganic adsorbent; separated from the solid inorganic adsorbent material to provide a purified dianhydride compound which is substantially free of the phase transfer catalyst
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008CA2256328C Novel n-acylsulphonamides, novel mixtures of herbicides and antidotes and their use
10/2008
10/30/2008WO2008128321A1 Therapeutic pro-antibiotic agents and methods of use thereof
10/30/2008WO2008022204A3 Thiourea compounds
10/30/2008US20080269509 producing a ketooleanolic acid that can be an intermediate for synthesis of pharmaceuticals; minimize the environmental pollution
10/30/2008US20080269507 Methods for Oxidizing Organic Compounds
10/30/2008US20080269505 Processes for preparing darifenacin hydrobromide
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
10/30/2008US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
10/30/2008US20080268462 Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits
10/30/2008CA2683512A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
10/29/2008EP1985614A1 Improved method for producing nitroguanidine derivative
10/29/2008EP1984333A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
10/29/2008EP1727809B8 Substituted morpholine and thiomorpholine derivatives
10/29/2008CN101296901A HIV-1 protease inhibitors, and methods of making and using them
10/29/2008CN101293884A (1S,2S)-1-(2-furyl)-1,2-propylene glycol or its analogue, preparation and application thereof
10/29/2008CN101293883A (1R)-1-(2-furfuran)-1-hydroxyl-2-acetone or its analogue, preparation and application thereof
10/29/2008CN101293834A 3,4-di-oxygen-[3-substituted alkene propionyl]quinic acid compounds and medicine uses thereof
10/29/2008CN101293830A 1-oxygen-[3-aryl substituted-alkene propionyl]quinic acid compounds and uses
10/29/2008CN100429209C Method for preparing phthalic anhydride
10/29/2008CN100429208C Process for prepn. of racemic citalopram and/or S-or R-citalopram by separation of mixture of R-and S-citalopram
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442833 e.g. (2E)-3-(4-{(1Z)-2-phenyl-1-[4-(propionyloxy)phenyl]but-1-enyl}phenyl)prop-2-enoic acid; postmenopausal disorders, depressive symptoms; acylating anisole with 2-phenylbutanoic acid followed by demethylation, dehydration to yield phenol aldehyde, acylation and carboxylation to yield ester prodrug
10/28/2008US7442816 Antimony vanadium phosphate
10/28/2008US7442815 Homo- or copolymerizing 2,2,3,3,4,5-hexafluoro-2,3-dihydrofuran derivative or fluorinated 1,2-didehydrooxetane, or dihydropyran derivative; transmittance and durability against short wavelength light; photolithography using KrF excimer lasers; clarity, radiation transparent
10/28/2008US7442810 of dicarboxylic acids and/or derivatives in the presence of hydrogenation catalysts, to form butanediol (BDO), butyrolacetone (GBL) and tetrahydrofuran (THF)
10/28/2008US7442808 e.g. 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline; with other active ingredients; agonists of G-protein coupled receptor 40 (GPR40); antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity, hyperlipemia
10/28/2008US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
10/28/2008US7442718 Inhibitors of aspartyl protease
10/28/2008US7442704 Amide derivatives
10/28/2008US7442702 Prostaglandin agonists
10/28/2008CA2382248C Production of maleic anhydride
10/28/2008CA2300319C 4-cyano-4-deformylsordaricin derivatives
10/23/2008WO2008127663A1 Method for reducing impurity level in mycophenolic acid fermentation
10/23/2008WO2008125616A2 Method for the purification of bio-molecules
10/23/2008WO2008081282A3 Process for the synthesis of n9-(3,5-dichloro-4-pyridyl)-6- difluoromethoxybenzo(4,5)furo(3,2-c)pyridine-9-carboxamide and salts thereof
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 472